BN Business News
Add your company to Business Communicator →

Konkurencja i konsument · 28/09/1998

Del Pharmaceuticals, Inc. Consents to Settle Allegations of Unfair Business Practices

Del Pharmaceuticals, Inc., and others have reached a consent agreement to settle allegations of violating federal law by engaging in unfair or deceptive business practices. The agreement includes terms that would settle these allegations, as outlined in the attached analysis.

Source: Federal Register — Federal Trade CommissionOpen original release →